FUFU vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

FUFU

40.0
AI Score
VS
HIVE Wins

HIVE

40.3
AI Score

Investment Advisor Scores

FUFU

40score
Recommendation
AVOID NEW MONEY

HIVE

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FUFU HIVE Winner
Forward P/E 5.2411 62.8931 FUFU
PEG Ratio 0 0 Tie
Revenue Growth -62.9% 73.5% HIVE
Earnings Growth 7683.6% -99.9% FUFU
Tradestie Score 40.0/100 40.3/100 HIVE
Profit Margin -29.3% -98.5% FUFU
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD HIVE

Relative Price Performance (Last 90 Days)

FUFU 1M: +13.8% · 3M: -2.8% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

FUFU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $1.40

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric FUFU HIVE
Market Cap — —
Forward P/E 10.0 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.7%
Gross Margin 0.1% 0.4%
Operating Margin -0.1% -0.6%
EPS -0.71 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.